This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Children's Medical Center Corporation. Active years: 2020-2026.
Company Filing History:
Years Active: 2020-2026
Title: Steven L Swendeman: Innovator in Lung Disease Treatment
Introduction
Steven L Swendeman is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of medical science, particularly in the treatment of lung diseases. With a total of 3 patents, his work focuses on innovative solutions that enhance patient care and treatment efficacy.
Latest Patents
Swendeman's latest patents include the development of ApoM-Fc fusion proteins for treating lung diseases. These fusion proteins comprise ApoM, which can be human or murine, fused to a constant region of immunoglobulin G (IgG). This innovative approach provides methods for treating lung disease effectively. Another significant patent involves engineered phospholipid or lysophospholipid chaperones derived from ApoM-Fc fusion proteins. These chaperones have an extended half-life in vivo and offer a safe and efficient means of delivering sphingosine 1-phosphate (S1P) to endothelial cells and various tissues throughout the body.
Career Highlights
Swendeman is associated with the Children's Medical Center Corporation, where he continues to advance his research and innovations. His work is pivotal in developing new therapeutic strategies that address complex medical challenges.
Collaborations
Some of his notable coworkers include Timothy T Hla and Annarita DiLorenzo. Their collaborative efforts contribute to the advancement of medical research and innovation.
Conclusion
Steven L Swendeman's contributions to the field of lung disease treatment through his innovative patents highlight his role as a leading inventor. His work not only enhances medical understanding but also improves treatment options for patients.